Claude

AI now acts as seven unhired employees talking to your customers. A new report shows how firms are losing millions and what they can do to take control.

A new partnership integrates Reddit's API with Emplifi's AI, promising to transform authentic community discussions into actionable business intelligence.

Greentown Labs names a decade-long veteran to lead its Boston hub, signaling a strategic shift to deepen regional impact after a period of restructuring.

As AI and privacy shifts threaten publishers, OpenX hires ad tech vets to bolster monetization and compete in the high-stakes CTV advertising market.

Moving beyond hype, ArisGlobal's record growth and enterprise adoption of its NavaX AI show the pharmaceutical industry is now operationalizing AI at scale.

Genomics giant Illumina launches a vast biological dataset with pharma partners, aiming to train AI and revolutionize how we find new medicines.

TradeStation's new protocol lets traders talk to their accounts via AI, heralding a new era of conversational finance, but not without significant risks.

The sports platform giant is teaming with OBB Media to produce films and series, aiming to control every aspect of the modern fan experience.

AI firm Owkin is leveraging NVIDIA's powerful computing to build a 'Biological Artificial Super Intelligence,' aiming to revolutionize drug discovery.

A new partnership embeds Claude AI into EHRs, delivering patient chart summaries in seconds and promising to free primary care doctors from digital paperwork.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

Manhattan Associates embeds agentic AI and advanced simulation tools into its platform, promising to boost retail productivity, profits, and customer loyalty.

Vocodia Holdings is acquiring PrivacyPal.ai to combat 'Shadow AI' and solve the 'Fidelity Paradox,' aiming to secure AI use for businesses and individuals.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

How a blend of private capital and pragmatic regulation is turning Singapore into a global hub for longevity research, pushing scientific and ethical boundaries.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

BizClik’s Net Zero Summit will feature an SGS workshop to help leaders turn complex ESG regulations into a strategic advantage amid global compliance shifts.

A new CompTIA report reveals high optimism for 2026, but achieving growth means navigating AI costs, a complex cyber landscape, and a major skills gap.

At CES 2026, Xthings redefines entry with new ULTRALOQ locks using facial recognition, palm veins, and UWB to make access truly invisible.

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.